BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38252822)

  • 1. Dancr-BRG1 regulates Nfatc1 transcription and Pgc1β-dependent metabolic shifts in osteoclastogenesis.
    Zhang Z; Meng Y; Lin T; Zhang Z; Tao Z; Yin H; Yang F; Zhou X
    Proc Natl Acad Sci U S A; 2024 Jan; 121(5):e2313656121. PubMed ID: 38252822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pueraria lobate Inhibits RANKL-Mediated Osteoclastogenesis Via Downregulation of CREB/PGC1β/c-Fos/NFATc1 Signaling.
    Park KH; Gu DR; Jin SH; Yoon CS; Ko W; Kim YC; Lee SH
    Am J Chin Med; 2017; 45(8):1725-1744. PubMed ID: 29121799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-128 plays a critical role in murine osteoclastogenesis and estrogen deficiency-induced bone loss.
    Shen G; Ren H; Shang Q; Zhang Z; Zhao W; Yu X; Tang J; Yang Z; Liang D; Jiang X
    Theranostics; 2020; 10(10):4334-4348. PubMed ID: 32292498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA AK077216 promotes RANKL-induced osteoclastogenesis and bone resorption via NFATc1 by inhibition of NIP45.
    Liu C; Cao Z; Bai Y; Dou C; Gong X; Liang M; Dong R; Quan H; Li J; Dai J; Kang F; Zhao C; Dong S
    J Cell Physiol; 2019 Feb; 234(2):1606-1617. PubMed ID: 30132869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Blimp1-Bcl6 axis is critical to regulate osteoclast differentiation and bone homeostasis.
    Miyauchi Y; Ninomiya K; Miyamoto H; Sakamoto A; Iwasaki R; Hoshi H; Miyamoto K; Hao W; Yoshida S; Morioka H; Chiba K; Kato S; Tokuhisa T; Saitou M; Toyama Y; Suda T; Miyamoto T
    J Exp Med; 2010 Apr; 207(4):751-62. PubMed ID: 20368579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Major vault protein (MVP) negatively regulates osteoclastogenesis via calcineurin-NFATc1 pathway inhibition.
    Yuan L; Zhao N; Wang J; Liu Y; Meng L; Guo S; Wiemer EAC; Chen Q; Mao Y; Ben J; Ma J
    Theranostics; 2021; 11(15):7247-7261. PubMed ID: 34158848
    [No Abstract]   [Full Text] [Related]  

  • 7. C/ebpα controls osteoclast terminal differentiation, activation, function, and postnatal bone homeostasis through direct regulation of Nfatc1.
    Chen W; Zhu G; Tang J; Zhou HD; Li YP
    J Pathol; 2018 Mar; 244(3):271-282. PubMed ID: 29083488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown of DANCR reduces osteoclastogenesis and root resorption induced by compression force via Jagged1.
    Zhang X; Zhao Y; Zhao Z; Han X; Chen Y
    Cell Cycle; 2019 Aug; 18(15):1759-1769. PubMed ID: 31213122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA Nron Inhibits Bone Resorption in Periodontitis.
    Li J; Jin F; Cai M; Lin T; Wang X; Sun Y
    J Dent Res; 2022 Feb; 101(2):187-195. PubMed ID: 34157883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA-Jak3:Jak3 coexpressed pattern regulates monosodium urate crystal-induced osteoclast differentiation through Nfatc1/Ctsk expression.
    Lee CP; Huang YN; Nithiyanantham S; Huang CM; Ko YC
    Environ Toxicol; 2019 Feb; 34(2):179-187. PubMed ID: 30387921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The L-type amino acid transporter LAT1 inhibits osteoclastogenesis and maintains bone homeostasis through the mTORC1 pathway.
    Ozaki K; Yamada T; Horie T; Ishizaki A; Hiraiwa M; Iezaki T; Park G; Fukasawa K; Kamada H; Tokumura K; Motono M; Kaneda K; Ogawa K; Ochi H; Sato S; Kobayashi Y; Shi YB; Taylor PM; Hinoi E
    Sci Signal; 2019 Jul; 12(589):. PubMed ID: 31289211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
    J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The deubiquitinase UCHL1 negatively controls osteoclastogenesis by regulating TAZ/NFATC1 signalling.
    Feng Z; Tao S; Huang Z; Zheng B; Kong X; Xiang Y; Zhang Q; Song H; Xu Z; Wei X; Zhao F; Chen J
    Int J Biol Sci; 2023; 19(8):2319-2332. PubMed ID: 37215988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cinchonine inhibits osteoclast differentiation by regulating TAK1 and AKT, and promotes osteogenesis.
    Jo YJ; Lee HI; Kim N; Hwang D; Lee J; Lee GR; Hong SE; Lee H; Kwon M; Kim NY; Kim HJ; Park JH; Kang YH; Kim HS; Lee SY; Jeong W
    J Cell Physiol; 2021 Mar; 236(3):1854-1865. PubMed ID: 32700766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STAT3 controls osteoclast differentiation and bone homeostasis by regulating NFATc1 transcription.
    Yang Y; Chung MR; Zhou S; Gong X; Xu H; Hong Y; Jin A; Huang X; Zou W; Dai Q; Jiang L
    J Biol Chem; 2019 Oct; 294(42):15395-15407. PubMed ID: 31462535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inhibitory effect of beta-lapachone on RANKL-induced osteoclastogenesis.
    Gu DR; Lee JN; Oh GS; Kim HJ; Kim MS; Lee SH
    Biochem Biophys Res Commun; 2017 Jan; 482(4):1073-1079. PubMed ID: 27913299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Babam2 negatively regulates osteoclastogenesis by interacting with Hey1 to inhibit Nfatc1 transcription.
    Jin F; Zhu Y; Liu M; Wang R; Cui Y; Wu Y; Liu G; Wang Y; Wang X; Ren Z
    Int J Biol Sci; 2022; 18(11):4482-4496. PubMed ID: 35864959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DANCR Mediates the Rescuing Effects of Sesamin on Postmenopausal Osteoporosis Treatment via Orchestrating Osteogenesis and Osteoclastogenesis.
    Yang Z; Feng L; Wang H; Li Y; Lo JHT; Zhang X; Lu X; Wang Y; Lin S; Tortorella MD; Li G
    Nutrients; 2021 Dec; 13(12):. PubMed ID: 34960006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Euphorbia factor L1 inhibits osteoclastogenesis by regulating cellular redox status and induces Fas-mediated apoptosis in osteoclast.
    Hong SE; Lee J; Seo DH; In Lee H; Ri Park D; Lee GR; Jo YJ; Kim N; Kwon M; Shon H; Kyoung Seo E; Kim HS; Young Lee S; Jeong W
    Free Radic Biol Med; 2017 Nov; 112():191-199. PubMed ID: 28774817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mTORC1 Inhibits NF-κB/NFATc1 Signaling and Prevents Osteoclast Precursor Differentiation, In Vitro and In Mice.
    Zhang Y; Xu S; Li K; Tan K; Liang K; Wang J; Shen J; Zou W; Hu L; Cai D; Ding C; Li M; Xiao G; Liu B; Liu A; Bai X
    J Bone Miner Res; 2017 Sep; 32(9):1829-1840. PubMed ID: 28520214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.